Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The Transplant Outcomes of a 10/10 Matched Unrelated Donor (MUD) Stem Cell Transplant (SCT) Is Similar to a HLA Identical Related Donor (RD) Transplant.

Catherine Veeder, MD, Sheila Davies, R.N., OCN, Christina Havey, R.N., John J. Maciejewski, MD, PhD, Sunita Nathan, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Jamile Shammo, MD, Henry C. Fung, MD

Blood (2009) 114 (22): 4346.

https://doi.org/10.1182/blood.V114.22.4346.4346

Published: 2009

Journal Articles

Disruption of CXCR4 Utilizing AMD3100 Bypasses Mobilization Deficiency Exhibited by CD26 −/− Mice and Results in Efficient Mobilization of Myeloid Progenitors

Laura A. Paganessi, Andrew L. Walker, Stephanie A. Gregory, MD, Henry C. Fung, MD, Kent W. Christopherson, II, PhD

Blood (2008) 112 (11): 3492.

https://doi.org/10.1182/blood.V112.11.3492.3492

Published: 2008

Journal Articles

Reversal of Renal Insufficiency after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Hande Hayirlioglu Tuncer, MD, John J. Maciejewski, MD, PhD, Stephanie A Gregory, MD, Henry C. Fung, MD

Blood (2008) 112 (11): 4330.

https://doi.org/10.1182/blood.V112.11.4330.4330

Published: 2008

Journal Articles

Evaluation of the Pharmacokinetics, Immunogenicity, and Safety of XmAb®2513 in the Ongoing Study XmAb2513-01: A Phase 1 Study of Every Other Week XmAb2513 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Patients with Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

Anas Younes, MD, Jonathan Zalevsky, PhD, Kristie A. Blum, MD, Mitchell R Smith, MD, PhD, Henry C. Fung, MD, David A Ramies, MD, Chris E Lawrence, PhD, Daniel Combs, BS, Jeffrey Bloss, MD

Blood (2008) 112 (11): 5012.

https://doi.org/10.1182/blood.V112.11.5012.5012

Published: 2008

Journal Articles

Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.

Antonio Jimenez, MD, Mohamed I. Farhat, MD, Stephanie A. Gregory, MD, Mohamad Kassar, MD, Alla Gimelfarb, MD, Marta Batus, MD, Julie Nangia, MD, Neel Shah, MD, Parameswaran Venugopal, MD, Melissa L. Larson, MD, Kent W. Christopherson, PHD, Henry C. Fung, MD

Blood (2007) 110 (11): 5044.

https://doi.org/10.1182/blood.V110.11.5044.5044

Published: 2007

Journal Articles

Hematopoietic Cell Transplantation - Comorbidity Index (HCT-CI) as a Surrgoate Marker for Predition of Transplant Outcome for Pateints (pts) with Multiple Myeloma (MM) Undergoing Autologous Stem Cell Transplantation (ASCT): High HCT-CI Score Predicts for Poor Outcome.

Mohamed I. Farhat, MD, Ronald Myint, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Mohamad Kassar, MD, Alla Gimelfarb, MD, Marta Batus, MD, Julie Nangia, MD, John Maciejewski, MD, Amanda Law, NP, Henry C. Fung, MD

Blood (2007) 110 (11): 5104.

https://doi.org/10.1182/blood.V110.11.5104.5104

Published: 2007

Journal Articles

Incorporating Target Immunotherapy into Standard Conditioning Regimen Prior to Autologous Stem Cell Transplantaion (ASCT) Improves the Transplant Outcome for Pateints with Relapsed/Refractroy B Cell Non-Hodgkin Lymphoma (B-NHL).

Mohamed I. Farhat, MD, Reem Karmali, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Mohamad Kassar, MD, Neel Shah, MD, Terrance Brooks, Henry C. Fung, MD

Blood (2007) 110 (11): 1911.

https://doi.org/10.1182/blood.V110.11.1911.1911

Published: 2007

Journal Articles

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

Kent W. Christopherson, PhD, Laura A. Paganessi, MA, Darilyn R. Rhoades, RN, Hortense M. Dillon, CMA, Sefer Gezer, MD, Melissa L. Larson, MD, Henry C. Fung, MD, Stephanie A. Gregory, MD

Blood (2007) 110 (11): 4711.

https://doi.org/10.1182/blood.V110.11.4711.4711

Published: 2007

Journal Articles

A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.

Amrita Y. Krishnan, MD, Auayporn Nademanee, MD, Andrew Raubitschek, MD, Henry C. Fung, MD, Arturo Molina, MD, David Yamauchi, MD, Peter M. Falk, MD, Ricardo Spielberger, MD, Joycelynne Palmer, PhD, Ni Chun Tsai, MS, MPH, Jeffrey Schriber, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 3043.

https://doi.org/10.1182/blood.V108.11.3043.3043

Published: 2006

Journal Articles

Predicting Steroid Refractroy Acute Gastrointestinal (GI) Acute Graft Versus Host Disease (AGVHD) by Assessment of Crypt Loss at Diagnosis.

Joshua Melson, MD, Ali Keshavarzian, MD, Shriram Jakate, MD, Sally Arai, MD, Stephanie A. Gregory, MD, Henry C. Fung, MD

Blood (2006) 108 (11): 2895.

https://doi.org/10.1182/blood.V108.11.2895.2895

Published: 2006

Journal Articles

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

Amrita Y. Krishnan, MD, Karen L. Chang, MD, Henry C. Fung, MD, Margaret O’Donnell, MD, Ravi Bhatia, MD, Ricardo Spielberger, MD, Vinod Pullarkat, MD, Anthony Stein, MD, Neil Kogut, MD, Mark Kirschbaum, MD, Ellen Bolotin, MD, Clarence SarkodeeAdoo, MD, Andrew Dagis, MS, Nigel Cheng, Stephen J. Forman, MD

Blood (2004) 104 (11): 5144.

https://doi.org/10.1182/blood.V104.11.5144.5144

Published: 2004

Journal Articles

The Use of Reduced Intensity Allogeneic Stem Cell Transplantation (alloSCT) for Recurrence after Autologous Stem Cell Transplantation (ASCT) in Hodgkin’s Disease (HD).

Amrita Y. Krishnan, MD, Auayporn Nademanee, MD, Henry C. Fung, MD, Leslie Popplewell, MD, Roberto Rodriguez, MD, Zaid Al Kadhimi, MD, Mark Kirschbaum, MD, Neil Kogut, MD, Andrew Raubitschek, MD, Jeffrey Schriber, MD, Jasmine Zain, MD, Eileen Smith, MD, Nigel Cheng, Dajun Qian, PhD, Arturo Molina, MD, Stephen J. Forman, MD

Blood (2004) 104 (11): 5115.

https://doi.org/10.1182/blood.V104.11.5115.5115

Published: 2004

NARROW

The Transplant Outcomes of a 10/10 Matched Unrelated Donor (MUD) Stem Cell Transplant (SCT) Is Similar to a HLA Identical Related Donor (RD) Transplant.

Disruption of CXCR4 Utilizing AMD3100 Bypasses Mobilization Deficiency Exhibited by CD26 −/− Mice and Results in Efficient Mobilization of Myeloid Progenitors

Reversal of Renal Insufficiency after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Evaluation of the Pharmacokinetics, Immunogenicity, and Safety of XmAb®2513 in the Ongoing Study XmAb2513-01: A Phase 1 Study of Every Other Week XmAb2513 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Patients with Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.

Hematopoietic Cell Transplantation - Comorbidity Index (HCT-CI) as a Surrgoate Marker for Predition of Transplant Outcome for Pateints (pts) with Multiple Myeloma (MM) Undergoing Autologous Stem Cell Transplantation (ASCT): High HCT-CI Score Predicts for Poor Outcome.

Incorporating Target Immunotherapy into Standard Conditioning Regimen Prior to Autologous Stem Cell Transplantaion (ASCT) Improves the Transplant Outcome for Pateints with Relapsed/Refractroy B Cell Non-Hodgkin Lymphoma (B-NHL).

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.

Predicting Steroid Refractroy Acute Gastrointestinal (GI) Acute Graft Versus Host Disease (AGVHD) by Assessment of Crypt Loss at Diagnosis.

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

The Use of Reduced Intensity Allogeneic Stem Cell Transplantation (alloSCT) for Recurrence after Autologous Stem Cell Transplantation (ASCT) in Hodgkin’s Disease (HD).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only